Open AccessWhy Do We Need Serological Tests for Severe Acute Respiratory Syndrome Coronavirus-2 Diagnosis?
Author(s) -
Bouchra Ghazi,
Adil Elghanmi
Publication year - 2020
Publication title -
bioresearch open access
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 26
eISSN - 2164-7860
pISSN - 2164-7844
DOI - 10.1089/biores.2020.0026
Subject(s) - serology , medicine , covid-19 , coronavirus , antibody , immunology , virology , intensive care medicine , disease , infectious disease (medical specialty)
Considering the COVID-19 emerging and rapidly evolving situation associated with increased levels of mortality and infectivity risks, the detection and identification of new tests in a fast, safe, and accurate measures would have a high impact regarding prompt clinical and epidemiological management decisions. The combination of real-time polymerase chain reaction and the immunoglobulin class M-immunoglobulin class G antibody serology testing can be a powerful strategy for more accurate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis with less false results slipping through the cracks. The following viewpoint is describing the immunological response to SARS-Cov-2 infection and its implication in the selection of the appropriate diagnosis tools.